In-Person EventFeb 10 - 12, 2014San Francisco, California, USA
Speakers
OVERVIEW
The ability to identify causal mutations and deliver a genetic diagnosis is the primary goal of personalized diagnostics. Identifying undiagnosed diseases with genomic tools will improve outcomes for patients and change the workflow in clinical centers. Furthermore, next gen sequencing (NGS) is being used with other techniques to offer a comprehensive diagnosis.
This conference will explore the best strategies for overcoming technical bottlenecks, gaining clinical adoption and commercializing tests for the personalized treatment of cancer, CV, and inherited diseases. Experts will be asked to share their experience on gaining regulatory approval.